BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26905262)

  • 41. The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer.
    Park JS; Lee JS; Kim EY; Jung JY; Kim SK; Chang J; Kim DJ; Lee CY; Jung I; Kim JH; Kim HR; Moon YW; Kim HS; Cho BC; Shim HS
    Lung Cancer; 2015 Jun; 88(3):325-31. PubMed ID: 25819384
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fibroblast growth factor receptor (FGFR) gene amplifications are rare events in bladder cancer.
    Fischbach A; Rogler A; Erber R; Stoehr R; Poulsom R; Heidenreich A; Schneevoigt BS; Hauke S; Hartmann A; Knuechel R; Veeck J; Gaisa NT
    Histopathology; 2015 Apr; 66(5):639-49. PubMed ID: 24898159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. FGF2/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells.
    Yuan H; Li ZM; Shao J; Ji WX; Xia W; Lu S
    J Exp Clin Cancer Res; 2017 May; 36(1):72. PubMed ID: 28558758
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer.
    Dutt A; Ramos AH; Hammerman PS; Mermel C; Cho J; Sharifnia T; Chande A; Tanaka KE; Stransky N; Greulich H; Gray NS; Meyerson M
    PLoS One; 2011; 6(6):e20351. PubMed ID: 21666749
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fibroblast growth factor receptors 1 and 4 combined with lymph node metastasis predicts poor prognosis in oral cancer.
    Gu ZY; Zhou R; Hong D; Han Y; Wang LZ; Li J; Zhang ZY; Shi CJ
    Oral Dis; 2024 Apr; 30(3):1004-1017. PubMed ID: 36938639
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate.
    Shiang CY; Qi Y; Wang B; Lazar V; Wang J; Fraser Symmans W; Hortobagyi GN; Andre F; Pusztai L
    Breast Cancer Res Treat; 2010 Oct; 123(3):747-55. PubMed ID: 20024612
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FGFR1 Amplification in Squamous Cell Carcinoma of the Lung with Correlation of Primary and Metastatic Tumor Status.
    Monaco SE; Rodriguez EF; Mahaffey AL; Dacic S
    Am J Clin Pathol; 2016 Jan; 145(1):55-61. PubMed ID: 26712871
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer.
    Wang R; Wang L; Li Y; Hu H; Shen L; Shen X; Pan Y; Ye T; Zhang Y; Luo X; Zhang Y; Pan B; Li B; Li H; Zhang J; Pao W; Ji H; Sun Y; Chen H
    Clin Cancer Res; 2014 Aug; 20(15):4107-14. PubMed ID: 24850843
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The 1.65 Å resolution structure of the complex of AZD4547 with the kinase domain of FGFR1 displays exquisite molecular recognition.
    Yosaatmadja Y; Patterson AV; Smaill JB; Squire CJ
    Acta Crystallogr D Biol Crystallogr; 2015 Mar; 71(Pt 3):525-33. PubMed ID: 25760602
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer.
    Kim HR; Kim DJ; Kang DR; Lee JG; Lim SM; Lee CY; Rha SY; Bae MK; Lee YJ; Kim SH; Ha SJ; Soo RA; Chung KY; Kim JH; Lee JH; Shim HS; Cho BC
    J Clin Oncol; 2013 Feb; 31(6):731-7. PubMed ID: 23182986
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma.
    von Loga K; Kohlhaussen J; Burkhardt L; Simon R; Steurer S; Burdak-Rothkamm S; Jacobsen F; Sauter G; Krech T
    PLoS One; 2015; 10(11):e0141867. PubMed ID: 26555375
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib.
    Hibi M; Kaneda H; Tanizaki J; Sakai K; Togashi Y; Terashima M; De Velasco MA; Fujita Y; Banno E; Nakamura Y; Takeda M; Ito A; Mitsudomi T; Nakagawa K; Okamoto I; Nishio K
    Cancer Sci; 2016 Nov; 107(11):1667-1676. PubMed ID: 27581340
    [TBL] [Abstract][Full Text] [Related]  

  • 53. AZD4547: an orally bioavailable, potent, and selective inhibitor of the fibroblast growth factor receptor tyrosine kinase family.
    Gavine PR; Mooney L; Kilgour E; Thomas AP; Al-Kadhimi K; Beck S; Rooney C; Coleman T; Baker D; Mellor MJ; Brooks AN; Klinowska T
    Cancer Res; 2012 Apr; 72(8):2045-56. PubMed ID: 22369928
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Theoretical studies on FGFR isoform selectivity of FGFR1/FGFR4 inhibitors by molecular dynamics simulations and free energy calculations.
    Fu W; Chen L; Wang Z; Kang Y; Wu C; Xia Q; Liu Z; Zhou J; Liang G; Cai Y
    Phys Chem Chem Phys; 2017 Feb; 19(5):3649-3659. PubMed ID: 28094372
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic value of fibroblast growth factor receptor 1 gene locus amplification in resected lung squamous cell carcinoma.
    Craddock KJ; Ludkovski O; Sykes J; Shepherd FA; Tsao MS
    J Thorac Oncol; 2013 Nov; 8(11):1371-7. PubMed ID: 24077455
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer.
    Seo AN; Jin Y; Lee HJ; Sun PL; Kim H; Jheon S; Kim K; Lee CT; Chung JH
    Virchows Arch; 2014 Nov; 465(5):547-58. PubMed ID: 25086725
    [TBL] [Abstract][Full Text] [Related]  

  • 57. FGFR1 expression and gene copy numbers in human lung cancer.
    Kohler LH; Mireskandari M; Knösel T; Altendorf-Hofmann A; Kunze A; Schmidt A; Presselt N; Chen Y; Petersen I
    Virchows Arch; 2012 Jul; 461(1):49-57. PubMed ID: 22648708
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SCLLTargeting FGFR1 to suppress leukemogenesis in syndromic and de novo AML in murine models.
    Wu Q; Bhole A; Qin H; Karp J; Malek S; Cowell JK; Ren M
    Oncotarget; 2016 Aug; 7(31):49733-49742. PubMed ID: 27391347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fibroblast Growth Factor Receptor 1 and Related Ligands in Small-Cell Lung Cancer.
    Zhang L; Yu H; Badzio A; Boyle TA; Schildhaus HU; Lu X; Dziadziuszko R; Jassem J; Varella-Garcia M; Heasley LE; Kowalewski AA; Ellison K; Chen G; Zhou C; Hirsch FR
    J Thorac Oncol; 2015 Jul; 10(7):1083-90. PubMed ID: 26020126
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fibroblast growth factor receptor 1 as a putative therapy target in colorectal cancer.
    Göke F; Göke A; von Mässenhausen A; Franzen A; Sharma R; Kirsten R; Böhm D; Kristiansen G; Stenzinger A; Wynes M; Hirsch FR; Weichert W; Heasley L; Buettner R; Perner S
    Digestion; 2013; 88(3):172-81. PubMed ID: 24135816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.